For the Inventor, By the Inventor

Enter inventor name

Convent Station, NJ, United States of America

Ronald J Doll

USPTO Granted Patents = 105 (Patent Applications = 4)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 5.8

ph-index = 21

Forward Citations = 1,141(Granted Patents)

Forward Citations (Not Self Cited) = 1,052(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Maplewood, NJ (US) (1984 - 2004)
Convent Station, NJ (US) (2004 - 2017)

Company Filing History:

92 out of 1,829

Schering Corporation

10 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Inc.

Pharmacopeia Drug Discovery, Inc.

Schering-plough Corporation

Schering Coporation

where one patent can have more than one assignee

Years Active: 1984-2017

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Hdm2 Inhibitors

P53 Activity

Cyclin Dependent Kinase Inhibitors

Erk Inhibitors

Ksp Kinesin Inhibitors

Farnesyl Protein Transferase Inhibitors

Androgen Dependent Diseases

Tricyclic Amides

Imidazopyridines

Pyrazolopyrimidines

Substituted Purines

Substituted Piperidines

105 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9637493 - Substituted pyrrolopyrimidines as HDM2 inhibitors (2017-05-02),

2. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors (2017-01-10),

3. 8987274 - Macrocycles that increase p53 activity and the uses thereof (2015-03-24),

4. 8962611 - Substituted imidazopyridines as HDM2 inhibitors (2015-02-24),

5. 8859776 - Substituted piperidines that increase p53 activity and the uses thereof (2014-10-14),

6. 8846657 - Substituted imidazopyridines as HDM2 inhibitors (2014-09-30),

7. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),

8. 8658651 - Compounds that are ERK inhibitors (2014-02-25),

9. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

10. 8546404 - Compounds that are ERK inhibitors (2013-10-01),

11. 7884107 - Substituted piperidines that increase P53 activity and the uses thereof (2011-02-08),

12. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors (2010-10-05),

13. 7807672 - Compounds that are ERK inhibitors (2010-10-05),

14. 7608643 - Compounds for inhibiting KSP kinesin activity (2009-10-27),

15. 7557107 - Farnesyl protein transferase inhibitors as antitumor agents (2009-07-07),

Title: The Innovative Journey of Ronald J Doll

Introduction: Ronald J Doll, a distinguished inventor hailing from Convent Station, NJ, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Ronald J Doll's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Ronald J Doll has a proven track record of developing innovative solutions to complex problems. His expertise lies in software development, cybersecurity, and medical device technology.

Collaborations: Throughout his career, Ronald J Doll has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His collaborative spirit has led to the successful implementation of cutting-edge technologies in various sectors.

Conclusion: Ronald J Doll's passion for innovation and his dedication to pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to have a lasting impact on the tech industry, making him a true pioneer in his field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…